Mason MD - Search Results

1

Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).

James ND, Spears MR, Clarke NW, Dearnaley DP, De Bono JS, Gale J, Hetherington J, Hoskin PJ, Jones RJ, Laing R, Lester JF, McLaren D, Parker CC, Parmar MKB, Ritchie AWS, Russell JM, Strebel RT, Thalmann GN, Mason MD, Sydes MR. James ND, et al. Among authors: mason md. Eur Urol. 2015 Jun;67(6):1028-1038. doi: 10.1016/j.eururo.2014.09.032. Epub 2014 Oct 6. Eur Urol. 2015. PMID: 25301760 Free article. Clinical Trial.

2

Use of carboplatin in germ cell tumors of the testis.

Horwich A, Mason M, Dearnaley DP. Horwich A, et al. Semin Oncol. 1992 Feb;19(1 Suppl 2):72-7. Semin Oncol. 1992. PMID: 1329224 Review.

3

The activity of single-agent carboplatin in advanced seminoma.

Horwich A, Dearnaley DP, A'Hern R, Mason M, Thomas G, Jay G, Nicholls J. Horwich A, et al. Eur J Cancer. 1992;28A(8-9):1307-10. doi: 10.1016/0959-8049(92)90505-v. Eur J Cancer. 1992. PMID: 1515239

4

Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors.

Horwich A, Dearnaley DP, Nicholls J, Jay G, Mason M, Harland S, Peckham MJ, Hendry WF. Horwich A, et al. J Clin Oncol. 1991 Jan;9(1):62-9. doi: 10.1200/JCO.1991.9.1.62. J Clin Oncol. 1991. PMID: 1702147 Clinical Trial.

5

A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer.

Quilty PM, Kirk D, Bolger JJ, Dearnaley DP, Lewington VJ, Mason MD, Reed NS, Russell JM, Yardley J. Quilty PM, et al. Among authors: mason md. Radiother Oncol. 1994 Apr;31(1):33-40. doi: 10.1016/0167-8140(94)90411-1. Radiother Oncol. 1994. PMID: 7518932 Clinical Trial.

6

Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group.

Bolger JJ, Dearnaley DP, Kirk D, Lewington VJ, Mason MD, Quilty PM, Reed NS, Russell JM, Yardley J. Bolger JJ, et al. Among authors: mason md. Semin Oncol. 1993 Jun;20(3 Suppl 2):32-3. Semin Oncol. 1993. PMID: 7684863 Clinical Trial. No abstract available.

7

The use of bisphosphonates in prostatic cancer.

Mason MD, Glaholm J, Dearnaley DP. Mason MD, et al. Clin Oncol (R Coll Radiol). 1994;6(2):77-8. doi: 10.1016/s0936-6555(05)80107-4. Clin Oncol (R Coll Radiol). 1994. PMID: 8018576 No abstract available.

8

Hypofractionated radiotherapy for muscle invasive bladder cancer in the elderly.

McLaren DB, Morrey D, Mason MD. McLaren DB, et al. Among authors: mason md. Radiother Oncol. 1997 May;43(2):171-4. doi: 10.1016/s0167-8140(97)01943-9. Radiother Oncol. 1997. PMID: 9192963

9

Randomized trials in early prostate cancer. II: hormone therapy and radiotherapy for locally advanced disease: a question is still unanswered. MRC PR07 Trial Management Group.

Mason MD, Brewster S, Moffat LE, Kirkbride P, Cowan RA, Malone P, Sydes M, Parmar MK. Mason MD, et al. Clin Oncol (R Coll Radiol). 2000;12(4):215-6. doi: 10.1053/clon.2000.9156. Clin Oncol (R Coll Radiol). 2000. PMID: 11005685 No abstract available.

10

Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.

Patterson H, Norman AR, Mitra SS, Nicholls J, Fisher C, Dearnaley DP, Horwich A, Mason MD, Huddart RA. Patterson H, et al. Among authors: mason md. Radiother Oncol. 2001 Apr;59(1):5-11. doi: 10.1016/s0167-8140(00)00240-1. Radiother Oncol. 2001. PMID: 11295200

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

333 results

Search Page